North America Joint R&D Lab
Focused on temperature-controlled energy delivery systems and AI-assisted treatment planning. Our facility supports advanced research in aesthetic medicine technologies.
Innovating Aesthetic Medicine Solutions
Empowering medical professionals and clinics through advanced technology, evidence-based protocols, and comprehensive support since 2023.
Explore Our R&D Achievements20+
Core patents
28
Peer-reviewed publications
$5M
Annual R&D investment
5
Active clinical studies
Research & Development at Kallos Horizon
Established in 2023, Kallos Horizon is building a technology-led path for modern aesthetic medicine—combining validated clinical protocols with dedicated partner support so practitioners can deliver exceptional care while building resilient, sustainable practices.
Asia Joint R&D Lab
Specializing in multi-modal platform integration and adaptive energy delivery systems, with technologies tailored to diverse patient demographics.
Clinical Validation Center
Conducting clinical studies to validate treatment efficacy and safety protocols, ensuring all technologies meet rigorous standards of clinical excellence.
AI Development Hub
Developing predictive AI algorithms for treatment planning and outcome prediction, trained on extensive clinical datasets for accuracy and reliability.
Core Technological Innovations
Our breakthrough technologies are designed to enhance treatment precision, safety, and accessibility for medical professionals worldwide.
FDA-Approved AI Treatment Planning
Our AI-assisted system provides personalized treatment recommendations with 90% prediction accuracy, helping clinicians optimize outcomes while minimizing risk.
Temperature-Controlled Energy Delivery
Proprietary technology that delivers precise energy to target tissues while protecting surrounding areas, validated through rigorous clinical testing.
Cloud-Based Clinical Management Suite
Integrated platform with 80+ evidence-based treatment protocols, practice management tools, and remote consultation capabilities for comprehensive clinic support.
Recent Research Highlights
Key findings and breakthroughs from our ongoing research initiatives in aesthetic medicine technology.
-
01
AI Treatment Planning Validation Study
Clinical study demonstrates 90% accuracy in predicting treatment outcomes for facial rejuvenation procedures.
Published in Aesthetic Medicine Journal
-
02
Next-Gen Adaptive Energy System
Prototype adaptive energy delivery system that responds to real-time tissue feedback.
Patent Pending
-
03
VR Training Efficacy Research
Study shows 35% improvement in procedural skill acquisition with VR simulation compared to traditional methods.
Presented at Aesthetic Conference 2023
-
04
Multi-Modal Platform Integration
Successful integration of diagnostic imaging with treatment planning systems for comprehensive patient care workflows.
CE Mark Approval Received
-
05
Collaboration with Seoul National University
Research partnership focused on biomaterials for minimally invasive aesthetic procedures.
Joint Research Project
-
06
Safety Protocol Development
Comprehensive safety protocols for non-invasive body contouring procedures.
Clinical Guideline Publication
Our Innovation Journey
Key milestones in our mission to advance aesthetic medicine through technology and innovation.
-
2023
Foundation of Kallos Horizon
Kallos Horizon was founded to give medical professionals smarter, safer tools for aesthetic practice—rooted in innovation, evidence, and long-term partnership.
-
2023 Q2
Core Technology Patents Filed
Initial patents for temperature-controlled energy delivery and multi-modal platform integration submitted.
-
2023 Q3
First Clinical Studies Initiated
Initial clinical trials launched to validate AI treatment planning accuracy and temperature control efficacy.
-
2023 Q4
AI Platform FDA Approval
Our AI treatment planning system received FDA approval for clinical use in aesthetic medicine.
-
2024 Q1
Academic Partnerships Established
Collaborations initiated with six leading academic institutions for research and development.
-
2024 Q2
San Francisco Headquarters
Headquarters established in San Francisco to support clinics in global markets.
-
2024 Q3
Research Milestone Achieved
28 peer-reviewed publications and 5 clinical studies completed, validating our technology platform.
Academic & Industry Collaborations
We partner with leading institutions to advance aesthetic medicine through research, development, and education.
-
Seoul National University
Short-term research collaboration
-
North American Medical Institute
Clinical research partnership
-
European Aesthetic Research Center
Technology validation studies
-
Asia-Pacific Medical University
Training program development
-
Clinical Research Network
Multi-center study collaboration
-
Biomedical Engineering Institute
Device development partnership
Join Our Innovation Journey
Partner with Kallos Horizon to advance aesthetic medicine. Explore research collaborations, clinical trial opportunities, or join our growing network of medical professionals.